INVESTMENT IN IMAGION BIOSYSTEMS

3 Months Ended

Mar. 31, 2021

NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS

As of March 31, 2021, the Company owns 52,516,508 shares of Imagion, resulting in a noncontrolling interest of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on March 31, 2021, approximately $0.12 per share, the fair value of the Imagion shares was approximately $6,199,000. During the three months ended March 31, 2021, the Company recorded an unrealized gain in its investment of $324,000.

Below is reconciliation for the changes to the investment in Imagion for the three months ended March 31, 2020:

Balance as of December 31, 2020	$	5,875,000
Change in the unrealized fair value of securities		324,000
Balance as of March 31, 2021	$	6,199,000